末梢血管インターベンション機器の世界市場:企業動向

◆英語タイトル:Peripheral Vascular Interventions - Current and Future Players
◆商品コード:GDME1049FPR
◆発行会社(調査会社):GlobalData
◆発行日:2016年3月14日
◆ページ数:※お問い合わせください。
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,385 ⇒換算¥597,735見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD8,300 ⇒換算¥921,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Peripheral Vascular Interventions – Current and Future Players
Summary

The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. Recent advancements in this field have greatly expanded the potential of therapeutic applications. The market for peripheral vascular interventions including lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents, is expected to grow steadily through 2022.

The report provides up-to-date information and in-depth analysis on the key players that shape this market. This includes an analysis of company market shares, industry trends, and corporate strategy. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of devices.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Benefits

“What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons, interventional cardiologists, and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Scope

- Investigation of current and future market competition in the peripheral vascular interventions market.
- Competitive Assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview, product portfolio assessment, and SWOT analysis.
- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

- Gain a high level view of the trends shaping and driving the peripheral vascular interventions market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Competitive Assessment
3.1 Market Share Analysis
3.1.1 North America
3.1.2 Europe
3.1.3 Asia-Pacific
3.1.4 South America
3.2 Key Companies and Product Profiles
3.2.1 Abbott Vascular
3.2.2 Biotronik
3.2.3 Boston Scientific
3.2.4 C.R. Bard
3.2.5 Cook Medical
3.2.6 Cordis (Cardinal Health)
3.2.7 Medtronic
3.2.8 Terumo
3.2.9 W.L. Gore
3.2.10 Other Players
3.3 Pipeline Products Assessment
4 Appendix
4.1 Bibliography
4.2 Abbreviations
4.3 Methodology
4.3.1 Overview
4.3.2 Coverage
4.3.3 Secondary Research
4.4 Forecasting Methodology
4.5 Physicians and Specialists Included in This Study
4.5.1 Key Opinion Leaders
4.6 Primary Research Summary
4.7 About the Authors
4.7.1 Analysts
4.7.2 Global Head of Medical Devices
4.7.3 About GlobalData
4.8 Disclaimer

1.1 List of Tables
Table 1: Abbott Vascular - Company SWOT Analysis
Table 2: Abbott Vascular - Marketed Products Assessment
Table 3: Abbott Vascular - Clinical Trials to Watch
Table 4: Biotronik - Company SWOT Analysis
Table 5: Biotronik - Marketed Products Assessment
Table 6: Biotronik - Clinical Trials to Watch
Table 7: Boston Scientific - Company SWOT Analysis
Table 8: Boston Scientific - Marketed Products Assessment
Table 9: Boston Scientific - Clinical Trials to Watch
Table 10: C.R. Bard - Company SWOT Analysis
Table 11: C.R. Bard - Marketed Products Assessment
Table 12: C.R. Bard - Clinical Trials to Watch
Table 13: Cook Medical - Company SWOT Analysis
Table 14: Cook Medical - Marketed Products Assessment
Table 15: Cook Medical - Clinical Trials to Watch
Table 16: Cordis (Cardinal Health) - Company SWOT Analysis
Table 17: Cordis (Cardinal Health) - Marketed Products Assessment
Table 18: Cordis (Cardinal Health) - Clinical Trials to Watch
Table 19: Medtronic - Company SWOT Analysis
Table 20: Medtronic - Marketed Products Assessment
Table 21: Medtronic - Clinical Trials to Watch
Table 22: Terumo - Company SWOT Analysis
Table 23: Terumo - Marketed Products Assessment
Table 24: Terumo - Clinical Trials to Watch
Table 25: W.L. Gore - Company SWOT Analysis
Table 26: W.L. Gore - Marketed Products Assessment
Table 27: W.L. Gore - Clinical Trials to Watch
Table 28: Other Players Assessment
Table 29: Other Clinical Trials to Watch
Table 30: Pipeline Products Assessment

1.2 List of Figures
Figure 1: North America Market Shares for Lower Extremity Stents, by Company, 2015
Figure 2: North America Market Shares for Standard PTA Balloons, by Company, 2015
Figure 3: North America Market Shares for PTA DEB, by Company, 2015
Figure 4: North America Market Shares for Carotid Stents, by Company, 2015
Figure 5: Europe Market Shares for Lower Extremity Stents, by Company, 2015
Figure 6: Europe Market Shares for Standard PTA Balloons, by Company, 2015
Figure 7: Europe Market Shares for PTA DEB, by Company, 2015
Figure 8: Europe Market Shares for Carotid Stents, by Company, 2015
Figure 9: APAC Market Shares for Lower Extremity Stents, by Company, 2015
Figure 10: APAC Market Shares for Standard PTA Balloons, by Company, 2015
Figure 11: APAC Market Shares for Standard PTA DEB, by Company, 2015
Figure 12: APAC Market Shares for Carotid Stents, by Company, 2015
Figure 13: South America Market Shares for Lower Extremity Stents, by Company, 2015
Figure 14: South America Market Shares for PTA Balloons, by Company, 2015
Figure 15: South America Market Shares for PTA DEB, by Company, 2015
Figure 16: South America Market Shares for Carotid Stents, by Company, 2015
Figure 17: Peripheral Vascular Survey Primary Research Participants, by Country

【掲載企業】

Abbott Vascular
Biotronik
Boston Scientific
C.R. Bard
Cook Medical
Cordis (Cardinal Health)
Medtronic
Terumo
W.L. Gore

★調査レポート[末梢血管インターベンション機器の世界市場:企業動向]販売に関する免責事項
★調査レポート[末梢血管インターベンション機器の世界市場:企業動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆